Molecular autopsy by proxy: relevance for genetic counseling in rare genetic disorders
- PMID: 38859940
- PMCID: PMC11163115
- DOI: 10.3389/fgene.2024.1400295
Molecular autopsy by proxy: relevance for genetic counseling in rare genetic disorders
Abstract
Background: Rare genetic disorders may result in death before a definitive clinical diagnosis is established.
Aim: This study aims to outline the processes and challenges in managing, from a genetic perspective, couples who lost children affected by rare genetic disorders.
Results: Six couples who experienced child loss due to rare genetic disorders, seen by the primary author at genetic evaluation and counseling sessions, were retrospectively analyzed. Four out of 6 couples reported consanguinity. Exome and genome sequencing were performed for the parents. Carrier status of two rare lethal metabolic disorders was confirmed in one consanguineous couple. Three couples were carriers of 3 other rare diseases. Variants of LYST, MPV17, HEXB, ITGB4, CD3E, ASPM, TK2, COL11A2, and LAMB3 genes were identified. Six out of 10 were pathogenic variants, out of which 4 correlated with the demised children's phenotypes. One couple was negative for pathogenic variants. The last couple did not undergo genetic testing since they were beyond the fertile window.
Conclusion: Appropriate parental genetic evaluation and counseling are mandatory for selecting the right genetic test to certify the diagnosis postmortem, by virtue of molecular autopsy by proxy. Clarifying a rare disorder diagnosis can help couples to avoid recurrence and plan early for their next pregnancies.
Keywords: autosomal recessive disorders; carrier testing; exome sequencing; genetic counseling; genetic testing; molecular autopsy by proxy.
Copyright © 2024 Skrypnyk and AlHarmi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- Ackerman M. J., Priori S. G., Willems S., Berul C., Brugada R., Calkins H., et al. (2011). HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart rhythm. 8 (8), 1308–1339. 10.1016/j.hrthm.2011.05.020 - DOI - PubMed
-
- Alamillo C. L., Powis Z., Kelly F., Kobori J. A., Jung J., Tang S., et al. (2016). Clinical diagnostic exome sequencing identified compound heterozygous ASPM gene alterations in a fetus with marked microcephaly [conference presentation abstract]. 2016 ACMG Annu. Clin. Genet. Meet. Tampa, FL, U. S.
LinkOut - more resources
Full Text Sources
Miscellaneous
